Meeting
2013 ASCO Annual Meeting
A retrospective study on the role of diabetes and metformin in colorectal cancer disease progression.
Authors
Ravi Ramjeesingh
Cancer Center of Southeastern Ontario, Kingston, ON, Canada
Ravi Ramjeesingh , Christine Orr , Lyndsay Richardson , Nazik Hammad
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention/Epidemiology
Track
Cancer Prevention/Epidemiology
Sub Track
Epidemiology
Citation
J Clin Oncol 31, 2013 (suppl; abstr 1593)
DOI
10.1200/jco.2013.31.15_suppl.1593
Abstract #
1593
Poster Bd #
8F
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Effect of dipeptidyl protease 4 (DPP4) inhibitors on progression-free survival in patients with metastatic renal cell carcinoma: A single-center retrospective analysis.
First Author: Soham Ali
Poster
2014 Gastrointestinal Cancers Symposium
Association of metformin with reduced mortality in patients with colorectal cancer: A systematic review and meta-analysis of observational studies.
First Author: Preet Paul Singh
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Does metformin use effect overall survival for patients with pancreatic cancer?
First Author: Ravi Ramjeesingh
Poster
2021 Genitourinary Cancers Symposium
A multicenter retrospective analysis examining the effect of dipeptidyl protease 4 (DPP4) inhibitors on progression-free survival in patients with prostate cancer.
First Author: Kelsey Pan